Boothbay Fund Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,942
| Closed | -$45.3K | – | 1821 |
|
|
2023
Q4 | $45.3K | Hold |
12,942
| – | – | ﹤0.01% | 1367 |
|
|
2023
Q3 | $46.1K | Hold |
12,942
| – | – | ﹤0.01% | 1434 |
|
|
2023
Q2 | $75.3K | Hold |
12,942
| – | – | ﹤0.01% | 1420 |
|
|
2023
Q1 | $489K | Hold |
12,942
| – | – | 0.01% | 1056 |
|
|
2022
Q4 | $386K | Hold |
12,942
| – | – | 0.01% | 1070 |
|
|
2022
Q3 | $432K | Sell |
12,942
-473
| -4% | -$15.8K | 0.01% | 1130 |
|
|
2022
Q2 | $537K | Hold |
13,415
| – | – | 0.01% | 997 |
|
|
2022
Q1 | $706K | Hold |
13,415
| – | – | 0.02% | 884 |
|
|
2021
Q4 | $743K | Hold |
13,415
| – | – | 0.02% | 746 |
|
|
2021
Q3 | $1.04M | Sell |
13,415
-1,287
| -9% | -$99.6K | 0.03% | 593 |
|
|
2021
Q2 | $1.91M | Hold |
14,702
| – | – | 0.06% | 338 |
|
|
2021
Q1 | $2.42M | Hold |
14,702
| – | – | 0.09% | 200 |
|
|
2020
Q4 | $3.44M | Buy |
14,702
+2,887
| +24% | +$676K | 0.13% | 117 |
|
|
2020
Q3 | $1.22M | Buy |
+11,815
| New | +$1.22M | 0.07% | 310 |
|